Get 15% Off on Memorial Day Sitewide Sale Get 15% Off on Memorial Day Sitewide Sale


Mylotarg: This Cancer Drug Kills Four Times More than No Treatment at All

Drugmaker Pfizer is pulling Mylotarg, a decade-old leukemia medicine, off the U.S. market after a study found a higher death rate and no benefit for patients.

Mylotarg won approval under an abbreviated process. Medicines cleared in that way have to pass follow-up tests to confirm they work.  The FDA asked Pfizer to withdraw the drug after a recent clinical trial raised concerns about the product's safety and clinical benefits.

Read the Full Article for Free!
Subscribe to the #1 Natural Health Newsletter
  • Unlock censored health information that Google doesn't want you to read
  • Keep your privacy secure — We are no longer active on Facebook and will soon be blocking our content from Google search to ensure your privacy stays protected
  • Get access to all of Dr. Mercola's health articles, E-books and special reports

Existing Subscribers: Enter your email address for instant access

You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy